Cargando…

Persistence of IgM Antibodies after Vaccination with Live Attenuated Japanese Encephalitis Vaccine

Japanese encephalitis (JE) is a vaccine-preventable, mosquito-borne disease. Substantial progress with JE control in Asia has been made during the past decade, with most endemic countries now having JE vaccination programs, commonly using live attenuated SA14-14-2 JE vaccine (trade name CD-JEV). If...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hills, Susan L., Van Keulen, Alex, Feser, Jodi, Panella, Amanda, Letson, G. William, Staples, J. Erin, Marfin, Anthony A., Brault, Aaron C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866339/ https://www.ncbi.nlm.nih.gov/pubmed/33236716 http://dx.doi.org/10.4269/ajtmh.20-1132

Ejemplares similares

Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial
por: Zaman, K., et al.
Publicado: (2022)

The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control
por: Vannice, Kirsten S., et al.
Publicado: (2021)

Immunogenicity and safety of concurrent or sequential administration of live, attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9–12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial
por: Capeding, Maria Rosario, et al.
Publicado: (2020)

Use of Japanese Encephalitis Vaccine in Children: Recommendations of the Advisory Committee on Immunization Practices, 2013
por: Bocchini, Joseph A., et al.
Publicado: (2013)

Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices
por: Hills, Susan L., et al.
Publicado: (2019)

Japanese Encephalitis Virus as Cause of Acute Encephalitis, Bhutan
por: Wangchuk, Sonam, et al.
Publicado: (2020)

Persistence of Immune Responses With an Inactivated Japanese Encephalitis Single-Dose Vaccine, JENVAC and Interchangeability With a Live-Attenuated Vaccine
por: Vadrevu, Krishna Mohan, et al.
Publicado: (2019)

The molecular determinants governing the immunogenicity of Japanese encephalitis live attenuated vaccines
por: Li, Yuhua, et al.
Publicado: (2017)

Japanese Encephalitis Vaccines
por: Satchidanandam, Vijaya
Publicado: (2020)

Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023
por: Hills, Susan L., et al.
Publicado: (2023)

Encephalitis temporally associated with live attenuated Japanese encephalitis vaccine: four case reports
por: Jia, Na, et al.
Publicado: (2011)

Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine
por: Bouckenooghe, Alain, et al.
Publicado: (2018)

Japanese encephalitis: The virus and vaccines
por: Yun, Sang-Im, et al.
Publicado: (2014)

Safety of Japanese encephalitis vaccines
por: Hu, Ya-Li, et al.
Publicado: (2021)

Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine
por: Wijesinghe, Pushpa Ranjan, et al.
Publicado: (2016)

Expanding japanese encephalitis vaccination to selected endemic indonesia provinces: A cost-effectiveness analysis
por: Kosen, Soewarta, et al.
Publicado: (2022)

An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia
por: Hills, Susan L., et al.
Publicado: (2022)

Multiplex Microsphere Immunoassays for the Detection of IgM and IgG to Arboviral Diseases
por: Basile, Alison J., et al.
Publicado: (2013)

Fatal Human Infection with Evidence of Intrahost Variation of Eastern Equine Encephalitis Virus, Alabama, USA, 2019
por: Hughes, Holly R., et al.
Publicado: (2021)

Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal
por: Upreti, Shyam Raj, et al.
Publicado: (2017)

Pre-cut Filter Paper for Detecting Anti-Japanese Encephalitis Virus IgM from Dried Cerebrospinal Fluid Spots
por: Bharucha, Tehmina, et al.
Publicado: (2016)

Investigation of immune response induction by Japanese encephalitis live‐attenuated and chimeric vaccines in mice
por: Fang, Enyue, et al.
Publicado: (2022)

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2021)

Rubella IgM epidemiology in the pre-rubella vaccination era in Uganda
por: Bagenda, Fred, et al.
Publicado: (2020)

Human IgM and IgG Responses to an Inactivated SARS-CoV-2 Vaccine
por: Banga Ndzouboukou, Jo-Lewis, et al.
Publicado: (2021)

Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from South-East Asia and India
por: Bonaparte, Matthew, et al.
Publicado: (2014)

The changing epidemiology of Japanese encephalitis and New data: the implications for New recommendations for Japanese encephalitis vaccine
por: Connor, Bradley, et al.
Publicado: (2017)

Changes in age-specific seroprevalence of Japanese encephalitis virus and impact of Japanese encephalitis vaccine in Korea
por: Kwak, Byung Ok, et al.
Publicado: (2021)

Japanese encephalitis vaccination in the Philippines: A cost-effectiveness analysis comparing alternative delivery strategies
por: Vodicka, Elisabeth, et al.
Publicado: (2020)

Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance
por: Hills, Susan, et al.
Publicado: (2009)

Past, Present, and Future of Japanese Encephalitis
por: Hills, Susan L., et al.
Publicado: (2009)

Dynamic changes of SARS-CoV-2 specific IgM and IgG among population vaccinated with COVID-19 vaccine
por: Chen, Fengling, et al.
Publicado: (2022)

Gianotti-Crosti syndrome following Japanese encephalitis vaccination.
por: Kang, Nam Gyu, et al.
Publicado: (2003)

Inactivated genotype 1 Japanese encephalitis vaccine for swine
por: Yang, Dong-Kun, et al.
Publicado: (2014)

The present and future of veterinary vaccines for Japanese encephalitis in Korea
por: Nah, Jin-Ju, et al.
Publicado: (2015)

Japanese Encephalitis Virus: An Update on the Potential Antivirals and Vaccines
por: Srivastava, Kumar Saurabh, et al.
Publicado: (2023)

Use of Japanese Encephalitis Vaccine in US Travel Medicine Practices in Global TravEpiNet
por: Deshpande, Bhushan R., et al.
Publicado: (2014)

Molecular and clinical relationship between live‐attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis
por: He, Dan, et al.
Publicado: (2018)

Japanese encephalitis virus live attenuated vaccine strains display altered immunogenicity, virulence and genetic diversity
por: Davis, Emily H., et al.
Publicado: (2021)

Anti Japanese encephalitis virus IgM positivity among patients with acute encephalitic syndrome admitted to different hospitals from all over Nepal
por: Bhattarai, Anupama, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qmgbivn8jel8qqef9vrf6bhmqf